EDRH
AST

Edmond de Rothschild Holding’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Edmond de Rothschild Holding’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-625
Closed -$3K – 892
2016
Q1 		$3K Hold
625
– – ﹤0.01% 803
2015
Q4 		$2K Hold
625
– – ﹤0.01% 811
2015
Q3 		$2K Hold
625
– – ﹤0.01% 820
2015
Q2 		$3K Buy
+625
New +$5.99K ﹤0.01% 802

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edmond de Rothschild Holding's AST Position: Q2 2016 in Review

Edmond de Rothschild Holding sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q2 2016, closing a stake of 625 shares — an estimated $3K sold.

Edmond de Rothschild Holding first reported a position in AST in Q2 2015 and held it in 4 quarters. The position peaked at $3K in Q1 2016. 66 funds tracked by Wall St. Rank hold AST as of Q2 2016.

  • Edmond de Rothschild Holding reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q2 2016 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 625 Asterias Biotherapeutics Inc. Series A shares in Q2 2016, an estimated $3K.
  • Edmond de Rothschild Holding first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2015 and held it in 4 quarters.
  • Edmond de Rothschild Holding's Asterias Biotherapeutics Inc. Series A position peaked at $3K in Q1 2016.
  • 66 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q2 2016.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2016, filed 10 Aug 2016.